Search Site

Trends banner

Ozempic maker lowers outlook

The company posted tepid Q3 results.

Kimberly-Clark to buy Kenvue

The deal is valued at $48.7 billion.

BYD Q3 profit down 33%

This was a 33% year-on-year decrease.

Alphabet posts first $100 bn quarter

The growth was powered by cloud division buoyed by AI

Nvidia to take stake in Nokia

Nvidia share price soars 20%.

Riyadh clears Moderna vaccine for people aged between 12 and 17

  • Clinical studies and reports showed the vaccine's effectiveness and safety
  • The Moderna COVID-19 vaccine was registered in the Kingdom on July 9, 2021

Saudi Arabia has approved the use of the Moderna Covid-19 vaccine for people aged between 12 and 17.

According to state news agency SPA the decision of the authority was based on the data provided by the pharmaceutical company, which showed its vaccine had met special regulatory requirements, and included clinical studies and reports showing its effectiveness and safety.

SFDA’s review found that the known and potential benefits of the vaccine on individuals 12 years of age or older outweigh the risks.

The Moderna COVID-19 vaccine was registered in the Kingdom on July 9, 2021 for those aged 17 years and older.